NCT05416333Early phase 1Active, not recruiting
Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
A Pilot Study of Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Early phase 1
- Sponsor
- Wake Forest University Health Sciences
- Participants (registry)
- 18
- Start
- August 2024
- Primary completion
- November 2026 (planned)
- Study completion
- December 2026 (planned)
- Last registry update
- July 2026
- Countries
- United States
Conditions studied: Central Centrifugal Cicatricial Alopecia
Interventions: azelaic acid, Finacea, usual medication for CCCA
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.